{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T20:34:35Z","timestamp":1740170075016,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s43441-022-00377-1","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T14:04:31Z","timestamp":1645538671000},"page":"454-463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Memory-Assisted Global Impression of Change (MAGIC)"],"prefix":"10.1007","volume":"56","author":[{"given":"Linda S.","family":"Deal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Andrae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela E.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Dell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"key":"377_CR1","unstructured":"Guy W. ECDEU Assessment Manual for Psychopharmacology\u2014Revised (DHEW Publ No ADM 76\u2013338). In: Department of Health E, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs, editors. Rockville 1976. 218\u20132."},{"key":"377_CR2","unstructured":"Public Law 114-255; 21st Century Cures Act (2016)."},{"key":"377_CR3","unstructured":"FDA Patient-Focused Drug Development Guidance Series for Enhancing the Incorporation of the Patient\u2019s Voice in Medical Product Development and Regulatory Decision Making 2020. Available from: https:\/\/www.fda.gov\/drugs\/development-approval-process-drugs\/fda-patient-focused-drug-development-guidance-series-enhancing-incorporation-patients-voice-medical"},{"key":"377_CR4","unstructured":"van Engen A. Prove it with PROs. International Society for Pharmacoeconomics and Outcomes Research (ISPOR): Europe; 10\u201314 November; Barcelona, 2018."},{"key":"377_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1477-7525-4-79","volume":"4","author":"Guidance for industry","year":"2006","unstructured":"Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79.","journal-title":"Health Qual Life Outcomes"},{"key":"377_CR6","unstructured":"Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims Washington, DC2009 (Available from: https:\/\/www.fda.gov\/downloads\/drugs\/guidances\/ucm193282.pdf)."},{"key":"377_CR7","unstructured":"Guidance 2 (DRAFT): Patient-Focused Drug Development: Methods to Identify What is Important to Patients 2018 (Available from: https:\/\/www.fda.gov\/media\/116277\/download)."},{"key":"377_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev.psych.49.1.289","volume":"49","author":"DL Schacter","year":"1998","unstructured":"Schacter DL, Norman KA, Koutstaal W. The cognitive neuroscience of constructive memory. Annu Rev Psychol. 1998;49:289\u2013318.","journal-title":"Annu Rev Psychol"},{"issue":"3","key":"377_CR9","first-page":"39","volume":"4","author":"JC Mundt","year":"2007","unstructured":"Mundt JC, Debrota DJ, Greist JH. Anchoring perceptions of clinical change on accurate recollection of the past: memory enhanced retrospective evaluation of treatment (MERET). Psychiatry (Edgmont (PA: Township)). 2007;4(3):39\u201345.","journal-title":"Psychiatry (Edgmont (PA: Township))"},{"issue":"5","key":"377_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1212\/WNL.17.5.427","volume":"17","author":"MM Hoehn","year":"1967","unstructured":"Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17(5):427\u201342.","journal-title":"Neurology"},{"key":"377_CR11","unstructured":"National Parkinson's Foundation. Parkinson's Outcomes Project 2018 (vailable from: http:\/\/parkinson.org\/research\/Parkinsons-Outcomes-Project)."},{"issue":"8","key":"377_CR12","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/mdc3.12833","volume":"6","author":"LS Deal","year":"2019","unstructured":"Deal LS, Flood E, Myers DE, Devine J, Gray DL. The Parkinson\u2019s disease activities of daily living, interference, and dependence instrument. Mov Disord Clin Pract. 2019;6(8):678\u201386.","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"377_CR13","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1037\/0033-2909.86.2.420","volume":"86","author":"PE Shrout","year":"1979","unstructured":"Shrout PE, Fleiss JL. Intraclass correlations: use in assessing rater reliability. Psychol Bull. 1979;86(2):420\u20138.","journal-title":"Psychol Bull"},{"issue":"2","key":"377_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155\u201363.","journal-title":"J Chiropr Med"},{"key":"377_CR15","doi-asserted-by":"crossref","unstructured":"Erratum to \"A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research\" [J Chiropr Med 2016;15(2):155\u2013163]. J Chiropr Med. 2017;16(4):346.","DOI":"10.1016\/j.jcm.2017.10.001"},{"issue":"4","key":"377_CR16","doi-asserted-by":"publisher","first-page":"61786","DOI":"10.1371\/journal.pone.0061786","volume":"8","author":"C Rottschy","year":"2013","unstructured":"Rottschy C, Kleiman A, Dogan I, Langner R, Mirzazade S, Kronenbuerger M, et al. Diminished activation of motor working-memory networks in Parkinson\u2019s disease. PLoS ONE. 2013;8(4):61786.","journal-title":"PLoS ONE"},{"key":"377_CR17","doi-asserted-by":"publisher","first-page":"572037","DOI":"10.3389\/fnagi.2020.572037","volume":"12","author":"J Salmi","year":"2020","unstructured":"Salmi J, Ritakallio L, Fellman D, Ellfolk U, Rinne JO, Laine M. Disentangling the role of working memory in Parkinson\u2019s disease. Front Aging Neurosci. 2020;12:572037.","journal-title":"Front Aging Neurosci."},{"issue":"3","key":"377_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/136828200410654","volume":"35","author":"RJ Holmes","year":"2000","unstructured":"Holmes RJ, Oates JM, Phyland DJ, Hughes AJ. Voice characteristics in the progression of Parkinson\u2019s disease. Int J Lang Commun Disord. 2000;35(3):407\u201318.","journal-title":"Int J Lang Commun Disord"},{"key":"377_CR19","unstructured":"Speech & Swallowing Problems 2021 (Available from: https:\/\/www.michaeljfox.org\/news\/speech-swallowing-problems)."},{"issue":"9","key":"377_CR20","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S0895-4356(02)00435-3","volume":"55","author":"GH Guyatt","year":"2002","unstructured":"Guyatt GH, Norman GR, Juniper EF, Griffith LE. A critical look at transition ratings. J Clin Epidemiol. 2002;55(9):900\u20138.","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"377_CR21","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0895-4356(97)00097-8","volume":"50","author":"GR Norman","year":"1997","unstructured":"Norman GR, Stratford P, Regehr G. Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. J Clin Epidemiol. 1997;50(8):869\u201379.","journal-title":"J Clin Epidemiol"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-022-00377-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-022-00377-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-022-00377-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T17:22:41Z","timestamp":1648574561000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43441-022-00377-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["377"],"URL":"https:\/\/doi.org\/10.1007\/s43441-022-00377-1","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"type":"print","value":"2168-4790"},{"type":"electronic","value":"2168-4804"}],"subject":[],"published":{"date-parts":[[2022,2,22]]},"assertion":[{"value":"19 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ms. Deal, Ms. Myers, and Mr. Dell are currently employees of Pfizer, Inc. and were so employed at the time the study was conducted. Their compensation includes company stock. Drs. Andrae, Evans, and Foster, and Mr. Johnson are, and were at the time of study, employees of Endpoint Outcomes, which conducted the study. The authors declare that there are no additional disclosures to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}